Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017GlobeNewswire (press release)RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automat… Continue reading
WEAU |
Stem cell recipient, donor share lifesaving story hoping to inspire others
WEAU Cody Cohen met his stem cell donor last week to celebrate and share their story. Cohen has met his donor Ormarie Vazquez-Silva before. They keep in touch and consider each other like family. Last Thursday, she and Cohen’s girlfriend donated platelets. |
|
Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC
EurekAlert (press release) SAN DIEGO, September 24, 2017 – A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the cancer. In the phase … Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapyMarkets Insider Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patientsDOTmed.com |
Markets Insider |
Renova Therapeutics leadership speaking at Cell & Gene Therapy CEO forum and Boulder Peptide Symposium
Markets Insider Boston Biotech Conferences’ Cell & Gene Therapy CEO is an off-the-record networking forum that brings together CEOs and decision-makers in cell therapy, gene therapy and regenerative medicine. Dr. Reich will be participating on a discussion panel on … |
Genetic Engineering & Biotechnology News |
Autologous CAR–T Cell Manufacturing: Current Standing and Future Directions
Genetic Engineering & Biotechnology News Following the approval of the first chimeric antigen receptor (CAR–T) cell construct by the FDA on August 30, 2017, industry stakeholders have been grappling with the many challenges of commercial-scale manufacturing of these types of therapies. |